Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Friday preview: Global factory PMIs, Rightmove in focus

(Sharecast News) - All eyes at the end of the week will be on a raft of factory sector survey results for the month of February due out across the world.

First out overnight will be Caixin's Chinese manufacturing sector Purchasing Managers' Index.

It will be followed early during the London session by final readings for S&P Global's comparable factory PMIs for the euro area and UK referencing the same month.

Later in the session, at 1500 GMT, America's ISM Institute will release its own factory PMI.

In parallel, the University of Michigan will release the final results for its February consumer confidence index.

Investors will also be keeping close tabs on what another batch of top Fed officials might have to say in speeches starting from 1515 GMT.

Investors in the euro area will also be keeping an eye out for a preliminary reading for consumer price inflation in the bloc due out at 1000 GMT.

Rightmove is among the corporate names due to update shareholders on Friday.

The real estate property website owner is expected to report a 9.1% jump in its top-line to reach £362.9m.

Underlying operating profits meanwhile are seen climbing 7.9% to reach £265m.

According to UBS analyst Jo Barnet-Lamb, investor focus will be on the company's 2024 guidance and what it might have to say about progress on adjacencies, which the broker believed was a focus area for the company.

Share this article

Related Sharecast Articles

AstraZeneca makes progress with two breast cancer treatments
(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.
Insurer Beazley keeps guidance after solid Q1 premiums growth
(Sharecast News) - Insurance group Beazley said that first-quarter results were in line with guidance with insurance written premiums (IWP) growing at high single digits.
Blackstone ups bid for Hipgnosis with $1.57bn offer
(Sharecast News) - Music rights owner Hipgnosis said it it agreed terms on a £1.2bn takeover by private equity investor Blackstone, in the latest tit-for-tat battle with rival Concord.
Aukett Swanke flags delays to some contracts
(Sharecast News) - Smart buildings, architectural and design services specialist Aukett Swanke said in an update on Friday that, as outlined in its recent financial statements, it maintained a robust pipeline of interest, although a number of projects had been pushed back.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.